Esperion Therapeutics reported $60.6M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Amarin AMRN:US USD 95.02M 62.25M
Amgen AMGN:US USD 4.61B 695M
Biogen BIIB:US USD 1.19B 1.45B
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Cytokinetics CYTK:US USD 133.2M 33.36M
Daiichi Sankyo 4568:JP JPY 308.93B 42.65B
Eli Lilly And LLY:US USD 5.47B 200.3M
Esperion Therapeutics ESPR:US USD 60.6M 10.61M
Geron GERN:US USD 40.24M 12.2M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
Intra Cellular Therapies ITCI:US USD 127.5M 16M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
Merk MRK:US USD 10.32B 624M
Minerva Neurosciences NERV:US USD 5.21M 1.76M
Moderna Inc MRNA:US USD 2.2B 104M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Pfizer PFE:US USD 19.12B 5.9B
Ptc Therapeutics PTCT:US USD 285.31M 27.43M
Puma Biotechnology PBYI:US USD 54.71M 7.19M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Sarepta Therapeutics SRPT:US USD 487.06M 42.45M
Seattle Genetics SGEN:US USD 703.1M 72.49M
United Therapeutics UTHR:US USD 201.7M 63.4M
Vanda Pharmaceuticals VNDA:US USD 61.41M 481K